Product
Tetrahydrobiopterin
Aliases
kuvan, sapropterin
Name
Kuvan
INN Name
SAPROPTERIN DIHYDROCHLORIDE
FDA Approved
Yes
2 clinical trials
1 organization
7 indications
1 document
Indication
Chronic Obstructive Pulmonary DiseaseIndication
Tetrahydrobiopterin DeficiencyIndication
Oxidative StressIndication
Intermittent ClaudicationIndication
IntermittentIndication
Peripheral Artery DiseaseIndication
Peripheral Vascular DiseasesClinical trial
Role of Nitric Oxide Coupling in Muscle Dysfunction With COPDStatus: Withdrawn, Estimated PCD: 2022-08-01
Clinical trial
The Effects of ATLAS (Arginine Tetrahydrobiopterin L-Ascorbate) Therapy on Nitric Oxide Bioavailability and Pain-free Walking in Patients With Intermittent ClaudicationStatus: Recruiting, Estimated PCD: 2025-07-01
Document
DailyMed Label: KuvanOrganization
BioMarin Pharmaceutical Inc.